Home leg heat therapy for people with peripheral artery disease
Tests heat treatment of the legs at home in people with peripheral artery disease.
Key facts
- Who runs it
- Indiana University
- Where
- Indianapolis, United StatesSee the site
- Trial code
- Registry title
- Leg Heat Therapy in Peripheral Artery Disease
- Status
- Recruiting
- People taking part
- 106 people, planned
- Started
- 7 Nov 2022
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Leg heat therapy
- Sham Control
- Record updated
- 17 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people over 50 with peripheral artery disease (narrowed leg arteries). It tests daily home leg heat therapy against a sham treatment.
- Age
- Older than 50 years
- Sex
- Men and women
- Disease stage
- Peripheral artery disease of the legs. Critical limb ischemia (pain at rest, non-healing wounds or tissue loss) cannot join.
- Earlier treatment
- No leg artery reopening (revascularization) or orthopedic surgery in the last 3 months. No prior foot or leg amputation.
- Biomarker or test result
- Resting ankle-brachial index (ABI, a blood pressure ratio of ankle to arm) of 0.9 or less in at least one leg. People with a resting ABI between 0.91 and 1.00 can join if it drops by 20% or more after a heel-rise test.
Main reasons for not taking part
- Walking limited by something other than leg pain, such as angina, arthritis or severe lung disease
- Use of a walking aid other than a cane
- Active cancer or severe kidney disease (eGFR <30)
- BMI ≥ 35 kg/m2 or unable to fit into the water-circulating trousers
- Mini-Mental Status Examination score <23 or reduced feeling of heat in the leg
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Men and women older than 50 years
- Resting ankle-brachial index (ABI) of 0.9 or less in at least one leg. Individuals with a resting ABI between 0.91 and 1.00 at baseline will be eligible if their ABI drops by 20% or greater following a heel-rise test
Who cannot take part
- Prior foot or leg amputation
- Recent (<3 months) lower-extremity revascularization or orthopedic surgery
- Exercise tolerance limited by factors other than leg pain (e.g. angina, arthritis, severe lung disease, etc)
- Active cancer
- Impaired thermal sensation in the leg; As this study involves MR imaging, patients that have contraindications to MRI will be included in the study but will not be allowed to participate in the MRI experiment. Information about biomedical devices that may pose a risk to patients undergoing MRI is available on the Internet at www.MRIsafety.com. These exclusions include: cardiac pacemaker, implanted cardiac defibrillator, aneurysm clips, carotid artery vascular clamp, neurostimulator, insulin or infusion pump, implanted drug infusion device, bone growth/fusion stimulator, cochlear, otologic, or ear implant and history of claustrophobia or who are unable to lie flat or who do not fit inside the bore of the scanner
- Chronic kidney disease (eGFR <30 by MDRD or Mayo or Cockcroft-Gault formula)
- Critical limb ischemia (ischemic rest pain or ischemia-related, non-healing wounds or tissue loss)
- Use of walking aid other than a cane
- Class 2 or 3 obesity (BMI ≥ 35 kg/m2)
- Unable to fit into water-circulating trousers
- A Mini-Mental Status Examination score <23
Where in United States
- Indiana University Health Methodist HospitalIndianapolis, United StatesContact: Janet Klein, RNTaking people
About the trial
What the trial wants to find out
The goal of this randomized, double-blind, sham-controlled clinical trial is to evaluate the benefits of home-based, leg heat therapy (HT) on lower-extremity functioning and quality of life in patients who suffer from lower-extremity peripheral artery disease (PAD). We will randomize 106 patients to one of two groups that either receive leg HT or a sham intervention. The primary study outcome is the change in 6-minute walk distance between baseline and the 12-week follow up. Secondary outcomes include changes in the short physical performance battery score, handgrip strength, quality of life (measured by the Walking Impairment Questionnaire and Short-Form (SF)-36 Questionnaire), calf muscle strength (measured using a calf ergometer), size (measured by magnetic resonance imaging) and bioenergetics (assessed using phosphorus-31 magnetic resonance spectroscopy), and physical activity (measured by accelerometer).
The 2 groups in the trial
- Heat therapyTreatment being tested
Patients will be provided with water-circulating trousers, a water heater, and a water tank coupled to a water pump. The heater will be adjusted to warm up the water to 42ºC. Participants will be asked to apply the therapy daily for 90 min while seated or in the supine position.
Treatment: Leg heat therapy
- Sham ControlExisting treatment, for comparison
Patients will be provided with water-circulating trousers, a water heater, and a water tank coupled to a water pump. The heater will be adjusted to warm up the water to 33ºC. Participants will be asked to apply the therapy daily for 90 min while seated or in the supine position.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Leg Heat Therapy to Improve Functional Performance in Peripheral Artery Disease
- Plain-language title
- Home leg heat therapy for people with peripheral artery diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 17 August 2026